Find your path to Melissa
Sign up to see every warm intro you have to Melissa
- Paths you didn't know you had: your email and LinkedIn already hold routes to Melissa. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Melissa Lezameta is a Senior Associate at Epidarex Capital, working in innovation, licensing, and partnering with a focus on oncology and neuroscience. She holds a Ph.D. in Neurobiology and has a background in cancer stem cells, immuno-oncology, CNS, and neural stem cells.
Contact· self-published, not guessed
Colleagues at Epidarex Capital
A. Sinclair Dunlop
Managing Partner at Epidarex Capital
Elizabeth Roper
General Partner at Epidarex Capital
Henning Steinhagen
Venture Partner at Epidarex Capital
Kyparissia Sirinakis
Managing Partner at Epidarex Capital
Lori Krim Gough
Partner at Epidarex Capital
Mary Canning
Partner at Epidarex Capital
Matthew Miessau
Principal at Epidarex Capital
Matthias Steinert
Investment Manager at SIB Innovations- und Beteiligungsgesellschaft
Frequently asked questions
- Who is Melissa Lezameta?
- Melissa Lezameta is a Senior Associate at Epidarex Capital, working in innovation, licensing, and partnering with a focus on oncology and neuroscience. She holds a Ph.D. in Neurobiology and has a background in cancer stem cells, immuno-oncology, CNS, and neural stem cells.
- Where does Melissa Lezameta work?
- Melissa Lezameta is Senior Associate at Epidarex Capital.
About this profile. Compiled from public sources — Epidarex Capital's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights







